Boehringer Ingelheim Venture Fund Overview
Boehringer Ingelheim Venture Fund (BIVF) focuses on investing in pioneering science that offers significant benefits for patients, targeting unprecedented therapeutic concepts addressing high medical needs in areas such as immuno-oncology, regenerative medicine, infectious diseases, and digital health. BIVF operates as an evergreen fund with a volume of €350 million, continually reinvesting to fuel its mission. The fund provides initial investments of up to €3 million at the early stage, with subsequent staged investments up to a total of €15 million per venture (up to €7.5 million for Digital Health) over its life. BIVF takes an active role with its portfolio companies, delivering added value through extensive drug discovery, scientific, and managerial expertise.
Is Boehringer Ingelheim Venture Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Boehringer Ingelheim Venture Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
Boehringer Ingelheim Venture Fund
Investment focus
Invest in
- Nordics
- Western Europe
- Central Eastern Europe
- North America
- Northern Africa
- Middle East
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- PharmaTech
Stages
Seed, Series A
First ticket size
€3,000,000 - €15,000,000
How to approach funds like Boehringer Ingelheim Venture Fund
When engaging Boehringer Ingelheim Venture Fund, founders should highlight the scientific novelty and translational potential of their technology, especially if it addresses a clear unmet medical need. Demonstrating robust early data and a credible path to clinical validation will resonate, as will a team with deep domain expertise and a collaborative mindset. BIVF values ventures that can leverage their hands-on support and benefit from their global pharma network, so founders should be prepared to articulate how BIVF’s involvement could accelerate both scientific and commercial milestones.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
